Endonovo Therapeutics Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals
13 juin 2019 08h30 HE | Endonovo Therapeutics Inc.
WOODLAND HILLS, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
lexaria.jpg
Lexaria Bioscience Corp. Featured in CannabisNewsAudio Broadcast on Dramatic Results of CBD Delivery System Study
13 juin 2019 08h30 HE | Lexaria Bioscience Corp.
NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announces the availability of an audio press release titled, “Dramatically...
lexaria.jpg
Lexaria Bioscience Corp. Featured in CannabisNewsWire Publication Describing Dramatic CBD Delivery System Improvements
12 juin 2019 08h35 HE | Lexaria Bioscience Corp.
NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announces its placement in an editorial published by CannabisNewsWire...
COSTAS Inc. (CSSI) Acquires Medical Nanotechnology Company, Appoints New Management and Board Members
06 juin 2019 01h08 HE | COSTAS Inc.
LAS VEGAS, June 06, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – COSTAS,Inc.  (OTC: CSSI), announces its acquisition of Atlas Nanotech (formerly known as Nano Creaciones SAPI de CV) in an all-stock...
lexaria.jpg
Lexaria Bioscience Corp. Featured in CannabisNewsAudio Broadcast Touting Impact of Technology on CBD Edible Space
31 mai 2019 08h30 HE | Lexaria Bioscience Corp.
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announces the availability of a CannabisNewsAudio Broadcast titled,...
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy Breakthroughs  
30 mai 2019 08h35 HE | Genprex, Inc.
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — GNPX)">Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted...
Sentia Medical Sciences Inc. Awarded Approximately $1.8 million Phase II Small Business Innovation Research (SBIR) Grant to Develop Astressins for the Treatment of Irritable Bowel Syndrome (IBS)
22 mai 2019 00h01 HE | Sentia Medical Sciences, Inc.
SAN DIEGO, May 22, 2019 (GLOBE NEWSWIRE) -- Sentia announced today that it has been awarded a phase II small business innovation research (SBIR) grant from the National Institute of Diabetes and...
imarc-FINAL.jpg
IMARC Research Focuses On Strategic Growth in 2020
21 mai 2019 07h30 HE | IMARC Research
STRONGSVILLE, Ohio, May 21, 2019 (GLOBE NEWSWIRE) -- IMARC Research is expanding its reach as a full-service, global contract research organization through several key promotions, new partnerships...
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
09 mai 2019 08h30 HE | Genprex, Inc.
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – GNPX)">Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “New Gene Therapies Hold Out...
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer Treatment
08 mai 2019 08h30 HE | Genprex, Inc.
NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — GNPX)">Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted...